RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma-Reference-Cited by-同舟云学术

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

Published:2017-02-10 Issue:10 Volume:31 Page:2104-2113
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Viziteu E,Klein B,Basbous J,Lin Y-L,Hirtz C,Gourzones C,Tiers L,Bruyer A,Vincent L^ORCID,Grandmougin C,Seckinger A,Goldschmidt H,Constantinou A,Pasero P,Hose D,Moreaux J^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201754.pdf

Reference62 articles.

1. Morgan GJ, Walker BA, Davies FE . The genetic architecture of multiple myeloma. Nat Rev Cancer 2012; 12: 335–348.

2. Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood 2012; 120: 1077–1086.

3. Magrangeas F, Avet-Loiseau H, Gouraud W, Lode L, Decaux O, Godmer P et al. Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia 2013; 27: 473–481.

4. Weston-Bell N, Gibson J, John M, Ennis S, Pfeifer S, Cezard T et al. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy. Leukemia 2013; 27: 1188–1191.

5. Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood 2012; 120: 1060–1066.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population;OncoImmunology;2024-08-18

2. Targeting chromosomal instability in patients with cancer;Nature Reviews Clinical Oncology;2024-07-11

3. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance;European Journal of Medicinal Chemistry;2024-05

4. Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma;Frontiers in Oncology;2023-12-06

5. Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma;Non-Coding RNA;2023-11-03